Contact
en
News

News

02. August 2021

Fundraising campaign for flood victims at FREY&LAU

On 14.07.2021, flash floods triggered by heavy rain rolled through the towns along the Ahr river. 134 people lost their lives. Thousands are homeless. Hundreds of buildings were swept away. A great wave of willingness to help and donate is now rolling through FREY&LAU. A donation campaign was quickly organised and three donation canisters were set up in the company and now opened on Thursday, 29.07.2021. The 270 employees of FREY&LAU donated no less than 2,096.60 euros. The management then increased the sum to 10,000 euros. FREY&LAU donated all the money to "Aktion Deutschland hilft".
mehr
02. July 2021

Vaccination campaign at FREY&LAU – Together against Corona

On Wednesday, 30 June 2021, all FREY&LAU employees and their relatives had the opportunity to be vaccinated by our company doctor, Dr Taubitz. Both first and second vaccinations were offered. A remarkable 101 vaccinations were carried out during this great campaign. Even the weather cooperated on this day - fortunately for all relatives - they of course had to wait outside the door to ensure safety for all participants. FREY&LAU hasn't had this many visitors since the 2019 summer party. Thanks to the great planning of the HR department, everything went smoothly, with little contact and to everyone's satisfaction.
mehr

Archive

04. June 2021

Sustainability at FREY&LAU

mehr
17. December 2020

An eventful year at FREY&LAU

mehr
06. August 2020

Signing of the IFRA-IOFI Sustainability Charta

mehr
load more
Fairs

Fairs

SEPAWA

13.10.2021 - 15.10.2021 / Berlin
Virtual Conference

Fi Europe

30.11.2021 - 02.12.2021 / Frankfurt
31C81

Pharma / GMP

As a leading manufacturer of essential oils that are suitable as active pharmaceutical ingredients (API), we ensure compliance with the highest standards when it concerns consumer protection and product safety for use in pharmaceuticals. We are producing for our customers within the scope of our European GMP certificate under GMP II active ingredients and are offering under our EGST-Line Eucalyptus oil GMP, Turpentine oil GMP, Peppermint oil GMP as well as several others. Because of our manufacturing license according to § 13 AMG we are able to produce high-quality pharmaceutical intermediate products under GMP I. For the approval process, product registration and to facilitate a fast market launch of our customers’ products, we offer complete ASMF solutions and documentation packages, as well as stability tests according to ICH Guidelines.

 

Products

 

The following product list will provide you with an overview of the essential oils that are suitable for use in pharmaceuticals.

 

PDF Download

 

 

GMP Manufacturing of Active Ingredients


Drug safety at the highest level: Active pharmaceutical ingredients (API) used in the production of pharmaceuticals must be manufactured in compliance with the Good Manufacturing Practice (GMP) principles. FREY&LAU fulfills all applicable requirements with a corresponding quality assurance system and is accordingly GMP-certified by the responsible authority. We are in possession of the manufacturing authorization for pharmaceuticals registered under the Eudralex Database, pursuant to § 13 AMG, which includes the authorization for further treatment of pharmaceutical intermediate products. Our GMP certificate enables us for essential oils and their constituents, to distil them, and to implement any additionally required steps necessary for the production and sale of essential oils as active pharmaceutical ingredients (API). Our product range currently encompasses 15 essential oils in API Quality.

ASMF


The simple route to register pharmaceutical products: We want to effectively and efficiently support our partners through the drug approval process. To this end, we offer comprehensive packages of qualified documents for seamless and transparent documentation. For the approval of essential oils as active ingredient components in pharmaceuticals, we create corresponding dossiers in our approval department for all active ingredient products in accordance with the European Drug Master File Procedure (ASMF). This allows us to meet the continuously growing challenges of European legislation. Moreover, we advise our customers extensively in direct contact with the responsible approval authorities, thus supporting numerous approval proceedings every year, all across Europe.
Back
Top